ID   BJAB/HR1K
AC   CVCL_B6UK
DR   cancercelllines; CVCL_B6UK
DR   Wikidata; Q111732960
RX   PubMed=62724;
RX   PubMed=175026;
RX   PubMed=8449221;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative cell line infected with EBV from P3HR-1 cell line (Cellosaurus=CVCL_2676).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 02-05-24; Version: 7
//
RX   PubMed=62724; DOI=10.1002/ijc.2910180513;
RA   Klein G., Zeuthen J., Terasaki P.I., Billing R.J., Honig R., Jondal M.,
RA   Westman A., Clements G.B.;
RT   "Inducibility of the Epstein-Barr virus (EBV) cycle and surface marker
RT   properties of EBV-negative lymphoma lines and their in vitro
RT   EBV-converted sublines.";
RL   Int. J. Cancer 18:639-652(1976).
//
RX   PubMed=175026; DOI=10.1002/ijc.2910170203;
RA   Fresen K.-O., zur Hausen H.;
RT   "Establishment of EBNA-expressing cell lines by infection of
RT   Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with
RT   different EBV strains.";
RL   Int. J. Cancer 17:161-166(1976).
//
RX   PubMed=8449221; DOI=10.1002/eji.1830230325;
RA   Uchanska-Ziegler B., Noessner E., Schenk A., Ziegler A., Schendel D.J.;
RT   "Soluble T cell receptor-like properties of an HLA-B35-specific
RT   monoclonal antibody (TU165).";
RL   Eur. J. Immunol. 23:734-738(1993).
//